![]() |
市场调查报告书
商品编码
1471431
口服补液盐市场:依形式、年龄层及分布划分-2024年至2030年全球预测Oral Rehydration Salts Market by Form (Capsules, Powder, Tablets), Age Group (Adult, Infant), Distribution - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年口服补液盐市场规模为30.8亿美元,预计2024年将达33.3亿美元,2030年将达53.8亿美元,复合年增长率为8.31%。
口服补液盐 (ORS) 是一种科学配製的葡萄糖、盐和矿物质混合物,可恢復身体必需的电解质和液体。这些化合物通常溶解在一定量的清水中,用于预防或治疗脱水,尤其是腹泻引起的脱水。溶液的渗透压和电解质浓度根据身体的需要精心定制,以促进小肠和体循环中快速有效的吸收。 ORS 已被证明是一种高效、安全且经济的治疗方法,特别是在治疗急性胃肠炎和霍乱等脱水疾病方面。口服补液盐市场的成长是由意识的提高、脱水的紧急缓解需求以及 ORS 配方的科学进步所推动的。口服补液盐市场遇到了仿冒品和产品召回事件的障碍。然而,注重口味和便利性的新产品创新显示全球口服补液盐市场的成长潜力。
主要市场统计 | |
---|---|
基准年[2023] | 30.8亿美元 |
预测年份 [2024] | 33.3亿美元 |
预测年份 [2030] | 53.8亿美元 |
复合年增长率(%) | 8.31% |
形式:粉末由于其多功能性和成本效益而成为脱水管理的首选。
胶囊是一种不太传统的 ORS 形式,由于易于吞嚥和方便而越来越受欢迎。胶囊是那些难以混合粉末或在旅行时需要快速、无需准备的选择的人的首选。胶囊还提供精确的剂量,消除了粉末製剂可能出现的剂量错误的可能性。粉状 ORS 因其成本效益、易于储存和给药弹性而非常受欢迎。适用于严重脱水或中暑等需要快速摄取大量液体的情况。粉末也非常适合儿童用,因为可以根据儿童的体重和脱水程度精确调整剂量。锭剂的便利性介于胶囊和粉末之间,特别受到旅行者和运动员的欢迎,因为他们可能无法立即获得干净的水源来混合粉末,但需要快速补水,这种情况很少见。
年龄层:成人越来越多地使用口服补液盐来治疗腹泻和脱水。
口服补液盐经过特别配製,可满足腹泻、呕吐和出汗过多等情况引起的水合需求。由于成人体型较大且代谢速度较快,因此成人通常比婴幼儿和儿童需要更高浓度的电解质和盐。成人的偏好可能会受到其他因素的影响,例如口味、包装便利性以及特定的饮食需求或限制。婴儿 ORS 溶液的配方可提供温和的电解质平衡,以适应婴儿敏感的消化器官系统。它具有低渗透压,可防止渗透性腹泻,并附带有关如何安全稀释的明确说明。婴儿需要 ORS 的原因与成人相似,但高钠血症或低钠血症的风险需要更仔细地考虑剂量和给药方法。当按年龄组比较 ORS 解决方案时,会出现一些差异。成人 ORS 配方倾向于强调高电解质含量和实用性,而婴儿 ORS 配方则专注于安全性和适当的电解质平衡,以满足婴儿的微妙需求。
分布:在药局购买 ORS 的趋势增加
便利商店和超级市场是口服补液盐的重要通路,因为消费者很容易获得这些管道。顾客经常选择这些商店进行紧急采购和日常杂货购物。公共卫生中心对于口服补液盐的分发至关重要,因为它们通常是寻求脱水相关症状治疗的人们的第一个接触点。这些健康中心经常直接向患者和客户分发口服补液盐,让任何寻求立即医疗监督治疗的人都可以使用它们。医疗中心也可能提供 ORS 样本或直接出售给您,以补充医疗专业人员建议的治疗。药局专门销售医疗产品,因此是口服补液溶液的重要配送中心。当顾客向药剂师寻求专业建议时,他们更愿意从药局购买,药剂师可以提供详细的用法和剂量建议。与药房和健康中心相比,便利商店和超级市场出售的产品更为一般,可能无法提供药剂师的专业建议。但他们透过延长营业时间以及週末和节日健康中心可能关闭的时间来弥补这一不足。
区域洞察
在美国和加拿大,口服补液盐是常见且广泛使用的成药,主要用于治疗胃肠炎、宿醉和体力消耗引起的脱水。这些国家的消费者更喜欢风味品牌 ORS,因为它被认为更高品质。此外,这些地区将 ORS 用于运动和健身目的的趋势日益明显。由于脱水疾病的流行,南美洲对 ORS 的需求量很大。公共卫生计划通常免费分发 ORS 来解决这些问题。在欧洲,德国拥有成熟的製药业,是 ORS 市场的驱动力。该国对临床研究和开发的重视催生了增强型 ORS 解决方案。欧盟严格的法规环境保证了在欧盟销售的ORS的安全性和有效性。客户的购买行为倾向于具有既定功效的值得信赖的品牌。在中东,由于气候炎热干燥,使用 ORS 会导致中暑和脱水。由于霍乱和腹泻等疾病的流行,特别是在幼儿中,非洲是口服补液盐的庞大市场。在清洁水和卫生设施有限的地区,对 ORS 的需求很高。国际援助机构经常与地方政府合作,协助分发 ORS,以防止脱水死亡。在亚太地区,中国、日本和印度等国家显着推动了 ORS 的需求。中国、日本、印度等国家由于水污染和不卫生的生活方式,腹泻病发生率很高。透过各种政府和非政府健康倡议,消费者对 ORS 预防脱水益处的认识不断提高。
FPNV定位矩阵
FPNV定位矩阵对于评估口服补液盐市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限。最前线 (F)、探路者 (P)、利基 (N) 和重要 (V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对口服补液盐市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该细分市场竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:包括新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:包括对未来技术、研发活动以及突破性产品开发的见解。
1.口服补液盐市场规模及预测是多少?
2.在口服补液盐市场的预测期间内,我们应该考虑投资哪些产品和应用?
3.口服补液盐市场的技术趋势和法规结构是什么?
4.口服补液盐市场主要供应商的市场占有率为何?
5. 进入口服补液盐市场的适当业态和策略手段是什么?
[185 Pages Report] The Oral Rehydration Salts Market size was estimated at USD 3.08 billion in 2023 and expected to reach USD 3.33 billion in 2024, at a CAGR 8.31% to reach USD 5.38 billion by 2030.
Oral rehydration salts (ORS) are a scientifically formulated mixture of glucose, salts, and minerals designed to restore the body's essential electrolytes and fluids. These compounds are generally dissolved in a specific amount of clean water and used to prevent or treat dehydration, particularly owing to diarrhea. The solution's osmolarity and electrolyte concentrations are meticulously aligned with the body's needs to facilitate rapid and efficient absorption both in the small intestine and the systemic circulation. ORS has been proven to be a highly effective, safe, and economical intervention in the management of dehydration, especially in cases of acute gastroenteritis and cholera. The oral rehydration salts market's growth is propelled by heightened awareness, urgent relief needs for dehydration, and scientific advancements in the formulation of ORS. The oral rehydration salts market encounters hurdles regarding counterfeit products and product recall incidents. However, new product innovations focused on taste and convenience, signaling a robust potential for the global oral rehydration salts market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.08 billion |
Estimated Year [2024] | USD 3.33 billion |
Forecast Year [2030] | USD 5.38 billion |
CAGR (%) | 8.31% |
Form: High preferences for powders in managing dehydration due to their versatility and cost-effectiveness
Capsules are one of the less traditional forms of oral rehydration salts (ORS) but have started to gain traction for their ease of swallowing and convenience. These are typically preferred by individuals who may have difficulty mixing powders or are traveling and need a quick, no-preparation option. Capsules also have a precise dose, eliminating the potential for dosing errors that can occur with powder formulations. Powder form ORS is highly popular owing to its cost-effectiveness, ease of storage, and flexibility in dosing. It is preferred in situations of acute dehydration where a high volume of fluids needs to be consumed quickly, such as in cases of severe diarrhea or heat illnesses. Powders are also ideal for pediatric use, as the dosage can be accurately adjusted to the child's weight and severity of dehydration. Tablets form a convenience between capsules and powders, which are particularly favored by travelers and athletes who may not have immediate access to a clean water source for mixing a powder, yet need rapid rehydration.
Age Group: Increasing usage of ORS among adults to cure diarrhea and dehydration
Oral rehydration salts (ORS) for adults are specifically formulated to meet the rehydration needs resulting from conditions such as diarrhea, vomiting, or excessive sweating. Adults typically require a higher concentration of electrolytes and salts compared to infants and children due to their larger body mass and higher metabolic rate. Preferences among adults may be influenced by additional factors such as taste, convenience in packaging, and specific dietary needs or restrictions. Infant ORS solutions are distinctively formulated with a gentle balance of electrolytes to suit the sensitive digestive systems of infants. These solutions are lower in osmolarity to prevent osmotic diarrhea and typically come with clear instructions for safe dilution practices. For infants, the need for ORS can arise from conditions similar to those of adults but requires more careful consideration of dosage and administration due to the risk of hypernatremia or hyponatremia. When comparing ORS solutions across age groups, several differences emerge. Adult ORS solutions tend to focus on a higher electrolyte content and practicality of use, whereas infant ORS solutions prioritize safety and appropriate electrolyte balancing to match an infant's delicate needs.
Distribution: Rising preferences for pharmacies to purchase ORS
Convenience stores and supermarkets represent a significant distribution channel for oral rehydration salts (ORS) due to their widespread availability and easy access for consumers. Customers often choose these outlets for emergency purchases or while shopping for daily groceries. Health centers are integral in the distribution of ORS as they are often the first point of contact during medical consultations for dehydration-related symptoms. These centers often distribute ORS directly to patients or clients, making it available for those seeking immediate treatment under medical supervision. Health centers may provide ORS samples or sell them directly to complement treatment advised by healthcare professionals. Pharmacies are a critical distribution point for oral rehydration solutions since they specialize in medically oriented products. Customers prefer to buy from pharmacies when seeking professional advice from pharmacists who can provide detailed usage instructions and dosage recommendations. Compared to pharmacies and health centers, convenience stores and supermarkets offer more general products and may not provide the specialized advice that comes from a pharmacist. However, they compensate with extended hours of operation and availability on weekends and holidays, which is when health centers might be closed.
Regional Insights
In the United States and Canada, oral rehydration salts (ORS) is commonly available and widely used, primarily as an over-the-counter remedy for dehydration caused by gastroenteritis, hangovers, or physical exertion. Consumers in these countries prefer flavored and branded ORS, perceived as being of higher quality. Moreover, these regions have a growing trend of using ORS for sports and fitness purposes. In South America, there is a significant need for ORS due to the prevalence of diseases causing dehydration. Public health programs often distribute ORS freely to address these issues. In Europe, Germany boasts a well-established pharmaceutical industry which acts as a driver for the ORS market. The country's strong emphasis on clinical research and development has led to the introduction of enhanced ORS solutions. The EU's stringent regulatory environment ensures that the ORS sold within its market is safe and effective. Customer purchasing behavior leans towards trusted brands with established efficacy. In the Middle East, ORS usage is associated with conditions such as heatstroke and dehydration due to the high temperatures and arid climate. Africa represents a vast market for ORS due to the high prevalence of diseases like cholera and diarrheal illnesses, particularly among children. The need for ORS is acute in regions with limited clean water and sanitation facilities. International aid organizations, along with local governments, often support the distribution of ORS to prevent dehydration-related deaths. The Asia Pacific region exhibits a significant demand for Oral Rehydration Salts (ORS), primarily driven by countries such as China, Japan, and India, as these countries have high incidences of diarrheal diseases due to factors such as water pollution and poor hygiene practices. Consumer awareness about the benefits of ORS in preventing dehydration is substantial because of various government and non-governmental health initiatives.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Oral Rehydration Salts Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Oral Rehydration Salts Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Oral Rehydration Salts Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, AstraEureka Pharmaceuticals, Cera Products Inc., Cian Healthcare Limited, Cipla Limited, Clinova Limited, FDC Limited, H2ORS, Inc., Halewood Laboratories Pvt. Ltd., Healthy Life Pharma Pvt. Ltd., Hind Pharma, KBI Pharmaceuticals GmbH & Co. KG, Niksan Pharmaceutical, Nutriset, Otsuka Pharmaceutical Co., Ltd., Phaedrus Life Science Pvt. Ltd, Pharma Biological, Shereya Life Sciences Pvt. Ltd., SK Agro Foodtech Pvt. Ltd., Trifecta Pharmaceuticals USA, LLC, Velnex Medicare, Wallace Pharma, Weefsel Pharma, and Wellona Pharma.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Oral Rehydration Salts Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Oral Rehydration Salts Market?
3. What are the technology trends and regulatory frameworks in the Oral Rehydration Salts Market?
4. What is the market share of the leading vendors in the Oral Rehydration Salts Market?
5. Which modes and strategic moves are suitable for entering the Oral Rehydration Salts Market?